Back to search
Immune Deficiencies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Deficiencies trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Deficiencies trials you may qualify forThe primary purpose of this study is to identify the recommended phase 2 dose (RP2D\[s\]) and schedule(s) to be safe for JNJ-79635322 in Part 1 (dose escalation…
The goal of this clinical trial is to evaluate whether psilocybin therapy can effectively treat depression and psychological distress in adult patients with COP…
This screening study will examine the causes of immune disorders affecting white blood cells, which defend against infections and will try to develop better mea…
Background: \- Researchers are interested in studying disorders that make individuals more susceptible to fungal infections, specifically infections with the C…
The goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and have amyloidosi…
By detailed sequence analysis and subsequent biophysical characterization of prototypic light chains, this project aims to identify sequence fingerprints in IGL…
This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02. AT-02 is an investigational medici…
This phase I/Ia trial finds the best dose and side effects of venetoclax given in combination with ixazomib citrate and dexamethasone in treating patients with…